Rockwell Medical, Inc. (NASDAQ:RMTI) Short Interest Up 25.3% in November

Rockwell Medical, Inc. (NASDAQ:RMTIGet Free Report) saw a large increase in short interest in November. As of November 15th, there was short interest totalling 1,120,000 shares, an increase of 25.3% from the October 31st total of 893,900 shares. Based on an average trading volume of 797,600 shares, the days-to-cover ratio is currently 1.4 days. Currently, 4.0% of the company’s stock are short sold.

Analyst Ratings Changes

Several research firms have weighed in on RMTI. Rodman & Renshaw began coverage on Rockwell Medical in a research note on Thursday, November 14th. They set a “buy” rating and a $5.00 target price on the stock. HC Wainwright lowered their target price on Rockwell Medical from $9.00 to $7.00 and set a “buy” rating on the stock in a research note on Monday, November 25th. StockNews.com cut Rockwell Medical from a “buy” rating to a “hold” rating in a research note on Thursday, November 21st. Finally, RODMAN&RENSHAW raised Rockwell Medical to a “strong-buy” rating in a research note on Thursday, November 14th.

View Our Latest Stock Report on RMTI

Institutional Investors Weigh In On Rockwell Medical

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Barclays PLC acquired a new stake in Rockwell Medical in the 3rd quarter worth approximately $90,000. XTX Topco Ltd lifted its holdings in shares of Rockwell Medical by 45.7% during the third quarter. XTX Topco Ltd now owns 28,455 shares of the company’s stock worth $113,000 after buying an additional 8,922 shares during the last quarter. Jane Street Group LLC bought a new stake in shares of Rockwell Medical during the third quarter valued at approximately $534,000. State Street Corp grew its position in Rockwell Medical by 21.5% in the third quarter. State Street Corp now owns 95,004 shares of the company’s stock valued at $377,000 after acquiring an additional 16,800 shares during the period. Finally, HighTower Advisors LLC grew its position in Rockwell Medical by 75.6% in the third quarter. HighTower Advisors LLC now owns 57,413 shares of the company’s stock valued at $228,000 after acquiring an additional 24,715 shares during the period. 23.31% of the stock is currently owned by institutional investors and hedge funds.

Rockwell Medical Stock Up 3.2 %

Shares of Rockwell Medical stock opened at $2.29 on Monday. The firm has a market cap of $74.01 million, a price-to-earnings ratio of -45.80 and a beta of 1.50. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.41 and a quick ratio of 2.00. Rockwell Medical has a 52-week low of $1.16 and a 52-week high of $5.15. The stock has a 50-day simple moving average of $3.35 and a 200-day simple moving average of $2.67.

Rockwell Medical Company Profile

(Get Free Report)

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.

Read More

Receive News & Ratings for Rockwell Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical and related companies with MarketBeat.com's FREE daily email newsletter.